HomeELAN • BMV
add
Elanco Animal Health Inc
Previous close
$321.62
Year range
$292.31 - $321.62
Market cap
5.78B USD
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.03B | -3.56% |
Operating expense | 543.00M | 0.74% |
Net income | 364.00M | 133.21% |
Net profit margin | 35.34 | 134.44% |
Earnings per share | 0.13 | -27.78% |
EBITDA | 165.00M | -23.26% |
Effective tax rate | 34.88% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 490.00M | 32.79% |
Total assets | 13.28B | -7.40% |
Total liabilities | 6.76B | -17.66% |
Total equity | 6.52B | — |
Shares outstanding | 494.35M | — |
Price to book | 24.37 | — |
Return on assets | -0.09% | — |
Return on capital | -0.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 364.00M | 133.21% |
Cash from operations | 162.00M | -18.18% |
Cash from investing | 1.24B | 3,555.56% |
Cash from financing | -1.34B | -753.50% |
Net change in cash | 74.00M | 3,600.00% |
Free cash flow | 919.62M | 508.02% |
About
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
Founded
1954
Website
Employees
9,550
